BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22276463)

  • 21. Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation.
    Pengo V; Cucchini U; Denas G; Davidson BL; Marzot F; Jose SP; Iliceto S
    Thromb Haemost; 2010 Feb; 103(2):442-9. PubMed ID: 20076843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.
    Fang MC; Stafford RS; Ruskin JN; Singer DE
    Arch Intern Med; 2004 Jan; 164(1):55-60. PubMed ID: 14718322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rosuvastatin-acenocoumarol interaction.
    Mondillo S; Ballo P; Galderisi M
    Clin Ther; 2005 Jun; 27(6):782-4. PubMed ID: 16117985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice.
    Abdelhafiz AH; Wheeldon NM
    Am J Geriatr Pharmacother; 2008 Mar; 6(1):1-11. PubMed ID: 18396243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prompt repeat testing after out-of-range INR values: a quality indicator for anticoagulation care.
    Rose AJ; Hylek EM; Berlowitz DR; Ash AS; Reisman JI; Ozonoff A
    Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):276-82. PubMed ID: 21505156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of low-dose amiodarone and magnesium combination on atrial fibrillation after coronary artery surgery.
    Cagli K; Ozeke O; Ergun K; Budak B; Demirtas E; Birincioglu CL; Pac M
    J Card Surg; 2006; 21(5):458-64. PubMed ID: 16948756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
    Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH;
    Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation.
    Lip GY
    Am J Med; 2011 Feb; 124(2):111-4. PubMed ID: 20887966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral anticoagulant therapy for heart disease: results in actual cardiology practice.
    Baggio D; Madore F; Lalonde G
    Can J Cardiol; 2000 Feb; 16(2):153-61. PubMed ID: 10694585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis and occurrence of adverse events with oral anticoagulant therapy.
    Schenk JF; Mörsdorf S; Pindur G; Munter KH; Thrun F; Tiaden JD; Wenzel E
    Semin Thromb Hemost; 1999; 25(1):65-71. PubMed ID: 10327223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rhabdomyolysis in association with simvastatin and amiodarone.
    Roten L; Schoenenberger RA; Krähenbühl S; Schlienger RG
    Ann Pharmacother; 2004 Jun; 38(6):978-81. PubMed ID: 15069169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
    Ripley TL; Harrison D; Germany RE; Adamson PB
    Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors of vitamin K antagonist overcoagulation.
    Marie I; Leprince P; Menard JF; Tharasse C; Levesque H
    QJM; 2012 Jan; 105(1):53-62. PubMed ID: 21880698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation.
    Kerin NZ; Faitel K; Naini M
    Arch Intern Med; 1996 Jan; 156(1):49-53. PubMed ID: 8526696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of anticoagulant and antiplatelet therapy in patients with spontaneous intra-cerebral hemorrhage: Does medication use predict worse outcome?
    Stead LG; Jain A; Bellolio MF; Odufuye AO; Dhillon RK; Manivannan V; Gilmore RM; Rabinstein AA; Chandra R; Serrano LA; Yerragondu N; Palamari B; Decker WW
    Clin Neurol Neurosurg; 2010 May; 112(4):275-81. PubMed ID: 20042270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleeding complication during coumarin therapy due to amiodarone and azithromycin.
    Bharat V; Mohanty B
    J Assoc Physicians India; 2000 Jul; 48(7):746-7. PubMed ID: 11273517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hospitalization for hemorrhage among warfarin recipients prescribed amiodarone.
    Lam J; Gomes T; Juurlink DN; Mamdani MM; Pullenayegum EM; Kearon C; Spencer FA; Paterson M; Zheng H; Holbrook AM
    Am J Cardiol; 2013 Aug; 112(3):420-3. PubMed ID: 23664078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.